schizandrin has been researched along with Disease Models, Animal in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, K; Cheng, X; Jia, Y; Jing, H; Qi, Y; Wu, B; Xiao, F; Yan, T | 1 |
| Kou, J; Li, F; Wang, G; Wang, T; Yu, B; Zhang, Y | 1 |
| Bi, K; Cheng, X; Du, Y; Gong, G; Jia, Y; Qi, Y; Wu, B; Yan, T | 1 |
| Lu, Y; Piao, Z; Song, L; Yao, L; Zhang, L | 1 |
| Bi, K; Gong, G; Jia, Y; Li, Y; Sun, Y; Wu, B; Yan, T; Zhang, J | 1 |
| Chu, C; Fan, XX; Kou, JP; Li, F; Yu, BY; Zhang, Y | 1 |
| Kong, L; Sun, H; Wang, XJ; Wang, XQ; Yu, JB; Zhang, AH; Zhang, QY | 1 |
| Cao, G; Cao, Z; Guo, Z; Kou, J; Li, L; Yang, H; Yu, B; Zhou, H | 1 |
| Ha, H; Lee, H; Lee, JA; Lee, KY; Lee, MY; Lee, NH; Seo, CS; Shin, HK | 1 |
| An, Y; Chang, Y; Chen, X; Fan, H; Huang, X; Lei, J; Liu, S; Liu, W; Ren, K; Shen, N; Wang, Y; Xu, N | 1 |
10 other study(ies) available for schizandrin and Disease Models, Animal
| Article | Year |
|---|---|
Combination of schisandrin and nootkatone exerts neuroprotective effect in Alzheimer's disease mice model.
Topics: Alzheimer Disease; Animals; Cyclooctanes; Disease Models, Animal; Glutathione; Lignans; Malondialdehyde; Maze Learning; Mice; Neuroprotective Agents; Oxidative Stress; Plant Extracts; Polycyclic Compounds; Polycyclic Sesquiterpenes; Superoxide Dismutase | 2019 |
Schizandrin Protects against OGD/R-Induced Neuronal Injury by Suppressing Autophagy: Involvement of the AMPK/mTOR Pathway.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Cyclooctanes; Disease Models, Animal; Glucose; Lignans; Mice; Models, Biological; Molecular Structure; Neurons; Neuroprotective Agents; Oxidation-Reduction; Oxygen; Polycyclic Compounds; Rats; Reperfusion Injury; Signal Transduction; Stroke; TOR Serine-Threonine Kinases | 2019 |
Synergistic neuroprotective effect of schisandrin and nootkatone on regulating inflammation, apoptosis and autophagy via the PI3K/AKT pathway.
Topics: Alzheimer Disease; Animals; Apoptosis; Autophagy; Cyclooctanes; Disease Models, Animal; Drug Synergism; Inflammation; Lignans; Mice; Neuroprotective Agents; PC12 Cells; Phosphatidylinositol 3-Kinases; Polycyclic Compounds; Polycyclic Sesquiterpenes; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; tau Proteins | 2020 |
Schisandrin ameliorates cognitive deficits, endoplasmic reticulum stress and neuroinflammation in streptozotocin (STZ)-induced Alzheimer's disease rats.
Topics: Alzheimer Disease; Animals; Cognition; Cognitive Dysfunction; Cyclooctanes; Disease Models, Animal; Endoplasmic Reticulum Stress; Lignans; Male; Phytotherapy; Polycyclic Compounds; Rats, Wistar; Schisandra; Sirtuin 1; Streptozocin; Up-Regulation | 2020 |
Antidepressant-like effects of Schisandrin on lipopolysaccharide-induced mice : Gut microbiota, short chain fatty acid and TLR4/NF-κB signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents; Bacteria; Behavior, Animal; Cyclooctanes; Cytokines; Depression; Disease Models, Animal; Dysbiosis; Fatty Acids, Volatile; Gastrointestinal Microbiome; Hippocampus; Host-Pathogen Interactions; Inflammation Mediators; Lignans; Lipopolysaccharides; Male; Mice, Inbred C57BL; Motor Activity; NF-kappa B; Polycyclic Compounds; Signal Transduction; Toll-Like Receptor 4 | 2020 |
A Strategy for Optimizing the Combination of Active Components Based on Chinese Medicinal Formula Sheng-Mai-San for Myocardial Ischemia.
Topics: Animals; Creatine Kinase, MB Form; Cyclooctanes; Disease Models, Animal; Drug Combinations; Drugs, Chinese Herbal; Ginsenosides; Heart; Isoproterenol; L-Lactate Dehydrogenase; Lignans; Medicine, Chinese Traditional; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Pituitary Hormones, Posterior; Polycyclic Compounds; Spirostans; Troponin I | 2018 |
Identifying quality-markers from Shengmai San protects against transgenic mouse model of Alzheimer's disease using chinmedomics approach.
Topics: Alzheimer Disease; Animals; Biomarkers, Pharmacological; Cyclooctanes; Dioxoles; Disease Models, Animal; Drug Combinations; Drugs, Chinese Herbal; Ginsenosides; Lignans; Male; Medicine, Chinese Traditional; Metabolomics; Mice, Transgenic; Neuroprotective Agents; Polycyclic Compounds | 2018 |
A combination of four active compounds alleviates cerebral ischemia-reperfusion injury in correlation with inhibition of autophagy and modulation of AMPK/mTOR and JNK pathways.
Topics: Adenine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autophagy; Brain; Brain Infarction; Cyclooctanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drugs, Chinese Herbal; Ginsenosides; Infarction, Middle Cerebral Artery; Lignans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Polycyclic Compounds; Renal Circulation; Reperfusion Injury; Saponins; Time Factors; TOR Serine-Threonine Kinases | 2014 |
Anti-asthmatic effect of schizandrin on OVA-induced airway inflammation in a murine asthma model.
Topics: Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cyclooctanes; Cytokines; Disease Models, Animal; Eosinophils; Female; Goblet Cells; Hyperplasia; Immunoglobulin E; Lignans; Lung; Mice; Mice, Inbred BALB C; Oxidative Stress; Polycyclic Compounds; Reactive Oxygen Species; Th1 Cells; Th2 Cells | 2010 |
[Effects of schizandrins on learning-memory disorder in mice].
Topics: Animals; Apoptosis; Behavior, Animal; CA1 Region, Hippocampal; Caspase 3; Cell Line; Cyclooctanes; Disease Models, Animal; Drugs, Chinese Herbal; Female; Learning Disabilities; Lignans; Male; Memory Disorders; Mice; Nitric Oxide; Oxidative Stress; PC12 Cells; Polycyclic Compounds; Proto-Oncogene Proteins c-bcl-2; Rats; Superoxide Dismutase; Transcription Factor RelA | 2011 |